Browsing Centre for Clinical Pharmacology by Subject "Myocardial infarction"
Now showing items 1-5 of 5
-
Complete versus culprit only revascularisation in patients with cardiogenic shock complicating acute myocardial infarction: Incidence and outcomes from The London Heart Attack Group.
(2019-06-18)BACKGROUND: Despite advances in technology, patients with Cardiogenic Shock (CS) presenting with ST-segment myocardial infarction (STEMI) still have a poor prognosis with high mortality rates. A large proportion of these ... -
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention.
(2017-10)Mortality and morbidity in patients with ST elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) are still high [1]. A huge amount of the myocardial damage is related to the ... -
Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection.
(2023-11)The present review summarizes the beneficial and detrimental roles of reactive oxygen species in myocardial ischemia/reperfusion injury and cardioprotection. In the first part, the continued need for cardioprotection beyond ...